We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
AGNC Investment
AGNC
$12.7B
| $7.22M | 0.02% |
363,058
+17,363
| +5% | +$335K |
|
802
Nektar Therapeutics
NKTR
$2.41B
| $7.19M | 0.02% |
20,428
+5,733
| +39% | +$1.29M |
|
803
Rayonier
RYN
$6.43B
| $7.19M | 0.02% |
279,496
+18,030
| +7% | +$461K |
|
804
Bank of Hawaii
BOH
$3.15B
| $7.18M | 0.02% |
87,152
+2,642
| +3% | +$225K |
|
805
Valmont Industries
VMI
$9.2B
| $7.15M | 0.02% |
46,007
+1,560
| +4% | +$230K |
|
806
ON Semiconductor
ON
$32.6B
| $7.15M | 0.02% |
461,695
+25,413
| +6% | +$368K |
|
|
SF
807
Stifel
SF
$12.5B
| $7.15M | 0.02% |
320,452
+14,290
| +5% | +$329K |
|
808
Crane NXT
CXT
$2.97B
| $7.15M | 0.02% |
274,950
+3,872
| +1% | +$99.1K |
|
809
AMC Global Media
AMCX
$427M
| $7.13M | 0.02% |
121,474
-41
| -0% | -$2.35K |
|
|
MDCO
810
DELISTED
Medicines Co
MDCO
| $7.12M | 0.02% |
145,547
+40,945
| +39% | +$1.87M |
|
|
EDR
811
DELISTED
Education Realty Trust Inc
EDR
| $7.06M | 0.02% |
172,748
+9,478
| +6% | +$388K |
|
|
TECD
812
DELISTED
Tech Data Corp
TECD
| $7.05M | 0.02% |
75,040
+2,678
| +4% | +$237K |
|
813
Nabors Industries
NBR
$1.22B
| $7.01M | 0.02% |
10,724
+730
| +7% | +$558K |
|
814
SS&C Technologies
SSNC
$18.6B
| $6.99M | 0.02% |
197,497
+12,016
| +6% | +$404K |
|
815
Cathay General Bancorp
CATY
$4.21B
| $6.97M | 0.02% |
185,010
+1,429
| +0.8% | +$54.3K |
|
816
Ryder
R
$9.9B
| $6.96M | 0.02% |
92,311
-2,449
| -3% | -$185K |
|
|
MBFI
817
DELISTED
MB Financial Corp
MBFI
| $6.96M | 0.02% |
162,599
+4,770
| +3% | +$214K |
|
|
BERY
818
DELISTED
Berry Global Group, Inc.
BERY
| $6.95M | 0.02% |
155,762
+10,123
| +7% | +$466K |
|
819
Cousins Properties
CUZ
$5.25B
| $6.94M | 0.02% |
209,858
+25,708
| +14% | +$863K |
|
|
UNIT
820
Uniti Group
UNIT
$2.26B
| $6.94M | 0.02% |
268,501
+18,161
| +7% | +$484K |
|
821
COPT Defense Properties
CDP
$4.35B
| $6.94M | 0.02% |
209,597
+15,590
| +8% | +$509K |
|
|
TUP
822
DELISTED
Tupperware Brands Corporation
TUP
| $6.92M | 0.02% |
110,358
+11,177
| +11% | +$661K |
|
|
S
823
DELISTED
Sprint Corporation
S
| $6.92M | 0.02% |
796,894
+88,396
| +12% | +$773K |
|
|
TXNM
824
TXNM Energy Inc
TXNM
$6.42B
| $6.91M | 0.02% |
186,847
+4,527
| +2% | +$160K |
|
|
COR
825
DELISTED
Coresite Realty Corporation
COR
| $6.91M | 0.02% |
76,738
+20,670
| +37% | +$1.8M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.